Risk factors and clinical outcomes associated with mitral annular calcification in hypertrophic obstructive

Bowen Guo1, Bangrong Song1, Xiaoyu Xu2

  • 1Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.

Insights

Mitral annular calcification (MAC) in hypertrophic obstructive cardiomyopathy (HOCM) patients is linked to adverse cardiac remodeling and worse outcomes. Identifying risk factors aids in patient management.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Imaging

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is a complex cardiac condition.
  • Mitral annular calcification (MAC) is a common finding in cardiovascular diseases.
  • The relationship between MAC and outcomes in HOCM patients is not fully understood.

Purpose of the Study:

  • To identify risk factors for mitral annular calcification (MAC) in patients with hypertrophic obstructive cardiomyopathy (HOCM).
  • To evaluate the association between MAC and clinical outcomes in HOCM patients undergoing septal myectomy.

Main Methods:

  • Retrospective analysis of 310 HOCM patients who underwent interventricular septal myectomy.
  • Comparison of demographic, echocardiographic, and clinical data between patients with and without MAC.
  • Multivariate analysis to identify independent risk factors for MAC.

Main Results:

  • Patients with MAC were older and had higher rates of aortic annular calcification, mitral leaflet thickening, and tricuspid regurgitation.
  • Independent risk factors for MAC included gender, age, aortic annular calcification, and mitral/tricuspid valve abnormalities.
  • MAC was associated with adverse cardiac remodeling (larger LV end-diastolic volume, reduced LVEF, greater LA mass) and a higher incidence of major adverse cardiovascular and cerebrovascular events (MACCE).

Conclusions:

  • Mitral annular calcification (MAC) is associated with adverse cardiac remodeling in HOCM patients.
  • MAC is linked to unfavorable clinical outcomes in HOCM patients undergoing septal myectomy.
  • Identifying MAC risk factors can improve risk stratification and perioperative management.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
483
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
223
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
393
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
381
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
423